findmyKOL

Beth McLellan, MD

Enriched profile

Chief, Dermatology; Director, Supportive Oncodermatology; Professor, Dermatology · Montefiore Einstein

ORCIDNPI
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Beth McLellan is Chief, Dermatology; Director, Supportive Oncodermatology; Professor, Dermatology at Montefiore Einstein. OpenAlex indexes 168 publications with 1,773 citations (h-index 20); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Beth N. McLellan, MD, is Chief, Dermatology at Montefiore Einstein (Montefiore Medical Center / Albert Einstein College of Medicine), Bronx, NY. The public record shows 168 publications with 1,773 citations (h-index 20), centered on Dermatology. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 3 companies.

  • Most recent indexed publication: 2025 · The oncologist
  • Top research focus: Dermatology
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 3 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Alopecia1 trial

Research focus

OpenAlex concept fingerprint
Dermatology

Drugs & molecules

across trials, industry payments and publications
Rybrevantgeneric · AmivantamabClinical trialsIndustry payments8Publications1Dupixentgeneric · DupilumabClinical trialsIndustry payments3PublicationsLibtayogeneric · CemiplimabClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Janssen Biotech, Inc.Clinical trialsIndustry payments4Janssen Scientific Affairs, LLCClinical trialsIndustry payments4Regeneron Healthcare Solutions, Inc.Clinical trialsIndustry payments4

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
168publications

Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.

1,773citations

Total citations across indexed works.

20h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
3companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    43.3%
    Corticosteroid25.1%
    Triamcinolone Acetonide78%Halobetasol Propionate23%
    Part D159 patients
    Interleukin-4 Receptor alpha Antagonist8.5%
    Dupixent Pen100%
    Part D20 patients
  • Anti-infectives

    21.7%
    Azole Antifungal12.7%
    Ketoconazole94%Fluconazole6%
    Part D<11 patients
    Lincosamide Antibacterial4.1%
    Clindamycin Phosphate100%
    Part D24 patients
  • Sensory organs

    13.6%
    Corticosteroid13.6%
    Hydrocortisone51%Clobetasol Propionate33%Betamethasone Dipropionate16%
    Part D55 patients
7 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)10.7% facility · 89.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/beth-mclellan-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/beth-mclellan-484b9626

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com

Mentions by others

where others cite or feature them
  • X / Twitter

    x.com/EinsteinDeptMed/status/1978199266783875159

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
  • LinkedIn

    LinkedIn profile: "Beth McLellan - Dermatology Chief & Professor at Albert Einstein" (auth-walled; title/employer corroborated via SERP snippet)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Wayne State University School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.montefioreeinstein.org
  • Board Certified

    Dermatology (American Board of Dermatology)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com
  • Dermatology residency

    Henry Ford Health System (served as Chief Resident); internal medicine internship, Loyola University Health System; supportive oncodermatology fellowship training …

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →einstein.yu.edu

Editorial & leadership roles

journal and society appointments
  • Chief

    Division of Dermatology, Montefiore Einstein

    2020
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.montefioreeinstein.org
  • Director of Resident Research

    Montefiore Einstein Dermatology Residency

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →einstein.yu.edu

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Director

    Dermatology, North Bronx Healthcare Network

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →usnews.com

Media & interviews

press, podcasts and appearances
1 more media item behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.